Home/Filings/4/0001209191-23-037910
4//SEC Filing

CHASE WILLIAM J 4

Accession 0001209191-23-037910

CIK 0001652130other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 4:30 PM ET

Size

7.2 KB

Accession

0001209191-23-037910

Insider Transaction Report

Form 4
Period: 2023-06-14
Transactions
  • Award

    Common Stock

    2023-06-14+1,67318,956 total
  • Award

    Stock Option (right to buy)

    2023-06-14+2,4472,447 total
    Exercise: $45.20Exp: 2033-06-13Common Stock (2,447 underlying)
Footnotes (2)
  • [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
  • [F2]This option was granted on June 14, 2023 with respect to 2,447 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

Issuer

Intellia Therapeutics, Inc.

CIK 0001652130

Entity typeother

Related Parties

1
  • filerCIK 0001563572

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:30 PM ET
Size
7.2 KB